sprite-preloader
Sonntag, 23.04.2017 Börsentäglich über 12.000 News von 561 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Passende Knock-Outs zu Ihrer Suchanfrage (Anzeige)
Erweiterte
Suche
lynx
Ad hoc-Mitteilungen

Aktuelle News von FierceBiotech

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
FrChutes & Ladders-Embattled Juno taps new R&D head
Fr'Priming' protein boosts stem cell response to injury
FrTonix could get 2019 nod for breakthrough-badged PTSD therapy
FrNovartis drug development chief outlines CAR-T research plans
FrH3 Biomedicine boosts its cancer collab with Foundation Medicine
FrAbbVie PARP inhibitor veliparib flunks two phase 3 trials
DoVerily kicks off Baseline study, which seeks to define 'health'
DoEU crushes U.K. hopes of retaining EMA after Brexit
DoTheranos squares away CMS, Arizona disputes to the tune of $4.6M
DoLion Biotechnologies teams with MD Anderson on TIL tech
DoNovartis signs collab deal with tiny Parvus for diabetes nanomedicine
MiMedidata adds eConsent to cloud platform with Mytrus buy
MiUltragenyx on course for XLH drug filing after phase 3 win
MiBoston Scientific leads $23M round for heart failure startup
MiOnkos Surgical bags $17M+ to boost 'aggressive growth'
MiAlpine bags Nivalis, making Gold a public biotech CEO again
MiCRUK, NCI fund Ras inhibitor tests, create commercial path
MiCardinal Health to fork over $6.1B for three Medtronic units
MiIonis teams up with Ribo to bring RNA drugs to China
MiCelgene in collab with Antengene, Tigermed as clinical support
MiNovartis gets second CAR-T candidate FDA 'breakthrough' tag
MiAllergan injects Tobira candidate into Novartis NASH combo trial
DiMotif Bio antibiotic hits endpoint in skin infection phase 3
DiCircassia scraps allergy program after another trial flops
DiHanmi hit over failure to disclose olmutinib cancer trial side effect